Seth A. Creasy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Seth A. Creasy has a total of 137 co-authors. Here are the top co-authors by number of shared publications:
Edward L. Melanson
Division of Endocrinology, Diabetes, and Metabolism, School of Medicine, University of Colorado Anschutz Medical Center, and Division of Geriatric Medicine, School of Medicine, University of Colorado Anschutz Medical Center, Aurora, Colorado (E.L.M.)
10 shared publications- Victoria A. Catenacci
Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA
9 shared publications - Edward L. Melanson
Division of Endocrinology, Metabolism, and Diabetes University of Colorado Anschutz Medical Campus Aurora Colorado USA
8 shared publications Victoria A. Catenacci
Division of Endocrinology, Metabolism, and Diabetes University of Colorado Anschutz Medical Campus Aurora Colorado USA
8 shared publicationsDaniel H. Bessesen
Department of Medicine, Division of Endocrinology, Metabolism, and Diabetes, University of Colorado Anschutz Medical Campus, Aurora, USA
7 shared publicationsZhaoxing Pan
Department of Biostatistics and Informatics, University of Colorado Anschutz Medical Campus, Aurora, Colorado (Z.P., L.K.K.)
7 shared publications
Latest Publications
- Open Access
- 10 November 2026
- Published by MDPI AG in Metabolites
- Vol. 16 (11) , 872
Time of Day of Aerobic Exercise Training Alters the Metabolome in Adults with Overweight or Obesity: A Secondary Analysis
Objective: The goal of this exploratory secondary analysis was to examine how time of day of aerobic exercise training alters fasting plasma metabolites in adults with overweight or obesity. Methods: Adults with overweight or obesity (n = 33, age 28–49, BMI: 25–40 kg/m2) were randomly assigned to AM (6:00–10:00) or PM (15:00–19:00) supervised aerobic exercise training for 15 weeks. Untargeted plasma metabolomics were performed in a subset of n = 28 participants who completed the intervention and provided fasted blood collections. This study is registered at clinicaltrials.gov (NCT04262115) as of 2/10/2020. Results: Following 15 weeks of aerobic exercise training, AM exhibited increased catecholamines (p < 0.05). This change in catecholamines was correlated with changes in HbA1C (r = −0.61, p = 0.01), such that larger increases in catecholamines were associated with larger decreases in HbA1C. Following 15 weeks of exercise training, PM exhibited increased serotonin (p = 0.04) and decreased L-tryptophanamide (p = 0.01), indole-3-acetate (p < 0.001), and indole-3-acetic acid (p < 0.001). Larger increases in plasma serotonin were correlated with larger increases in VO2 max (mL/kg/min) (r = 0.73, p = 0.01). Conclusions: In conclusion, time of day of aerobic exercise differentially impacted plasma metabolomic profiles, which were correlated with cardiometabolic health indicators. This study provides preliminary evidence that the timing of exercise may differentially impact physiological systems, which may, in turn, lead to differential effects on clinical health parameters.
- 10 November 2026
- Published by MDPI AG in Metabolites
- Vol. 16 (11) , 872
Open AccessTime of Day of Aerobic Exercise Training Alters the Metabolome in Adults with Overweight or Obesity: A Secondary Analysis
Objective: The goal of this exploratory secondary analysis was to examine how time of day of aerobic exercise training alters fasting plasma metabolites in adults with overweight or obesity. Methods: Adults with overweight or obesity (n = 33, age 28–49, BMI: 25–40 kg/m2) were randomly assigned to AM (6:00–10:00) or PM (15:00–19:00) supervised aerobic exercise training for 15 weeks. Untargeted plasma metabolomics were performed in a subset of n = 28 participants who completed the intervention and provided fasted blood collections. This study is registered at clinicaltrials.gov (NCT04262115) as of 2/10/2020. Results: Following 15 weeks of aerobic exercise training, AM exhibited increased catecholamines (p < 0.05). This change in catecholamines was correlated with changes in HbA1C (r = −0.61, p = 0.01), such that larger increases in catecholamines were associated with larger decreases in HbA1C. Following 15 weeks of exercise training, PM exhibited increased serotonin (p = 0.04) and decreased L-tryptophanamide (p = 0.01), indole-3-acetate (p < 0.001), and indole-3-acetic acid (p < 0.001). Larger increases in plasma serotonin were correlated with larger increases in VO2 max (mL/kg/min) (r = 0.73, p = 0.01). Conclusions: In conclusion, time of day of aerobic exercise differentially impacted plasma metabolomic profiles, which were correlated with cardiometabolic health indicators. This study provides preliminary evidence that the timing of exercise may differentially impact physiological systems, which may, in turn, lead to differential effects on clinical health parameters.
- 1 August 2026
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 179 (8) , 1085-1093
Prolonged Short Sleep and Its Effect on Body Weight and Composition
Insufficient sleep is associated with obesity. However, the causal effect on weight status of chronic, mildly insufficient sleep and its potential variability by gender and menopausal status remain unknown. To explore the effect of 6 weeks of sleep restriction (SR) of 1.5 hours per night on energy balance and body weight regulation. Pooled analysis of 2 randomized crossover trials. (ClinicalTrials.gov: NCT02960776 and NCT02835261). Outpatient intervention with inpatient and outpatient assessments. Adults (n = 95) aged 20 years or older at elevated cardiometabolic risk with habitual sleep of 7 or more hours per night. Six weeks of sustained adequate sleep (AS) and SR of 1.5 hours per night separated by a multiweek washout. Outcome measures included adiposity (assessed using magnetic resonance imaging), body weight, waist circumference, and energy balance behaviors and biomarkers. Sleep duration was reduced by 78.4 minutes (95% CI, -83.5 to -73.3 minutes) per night with SR versus AS. Body weight (0.45 kg [CI, 0.33 to 0.57 kg]), waist circumference (0.52 cm [CI, 0.25 to 0.79 cm]), and whole-body volume (0.56 L [CI, 0.19 to 0.93 L]) were increased with SR relative to AS. Leptin levels were elevated with SR versus AS (2.03 ng/mL [CI, 0.38 to 3.68 ng/mL]). Sedentary time was increased by 17.2 minutes (CI, 11.7 to 22.7 minutes) per day with SR versus AS. The intervention duration may have been too short to identify changes in body composition, power to evaluate individual differences was limited, and effect sizes were modest. Prolonged exposure to moderately short sleep may lead to weight gain, suggesting that weight management and cardiometabolic disease prevention programs should consider incorporating sleep strategies to promote AS. National Institutes of Health and American Heart Association.
- 1 August 2026
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 179 (8) , 1085-1093
Prolonged Short Sleep and Its Effect on Body Weight and Composition
Insufficient sleep is associated with obesity. However, the causal effect on weight status of chronic, mildly insufficient sleep and its potential variability by gender and menopausal status remain unknown. To explore the effect of 6 weeks of sleep restriction (SR) of 1.5 hours per night on energy balance and body weight regulation. Pooled analysis of 2 randomized crossover trials. (ClinicalTrials.gov: NCT02960776 and NCT02835261). Outpatient intervention with inpatient and outpatient assessments. Adults (n = 95) aged 20 years or older at elevated cardiometabolic risk with habitual sleep of 7 or more hours per night. Six weeks of sustained adequate sleep (AS) and SR of 1.5 hours per night separated by a multiweek washout. Outcome measures included adiposity (assessed using magnetic resonance imaging), body weight, waist circumference, and energy balance behaviors and biomarkers. Sleep duration was reduced by 78.4 minutes (95% CI, -83.5 to -73.3 minutes) per night with SR versus AS. Body weight (0.45 kg [CI, 0.33 to 0.57 kg]), waist circumference (0.52 cm [CI, 0.25 to 0.79 cm]), and whole-body volume (0.56 L [CI, 0.19 to 0.93 L]) were increased with SR relative to AS. Leptin levels were elevated with SR versus AS (2.03 ng/mL [CI, 0.38 to 3.68 ng/mL]). Sedentary time was increased by 17.2 minutes (CI, 11.7 to 22.7 minutes) per day with SR versus AS. The intervention duration may have been too short to identify changes in body composition, power to evaluate individual differences was limited, and effect sizes were modest. Prolonged exposure to moderately short sleep may lead to weight gain, suggesting that weight management and cardiometabolic disease prevention programs should consider incorporating sleep strategies to promote AS. National Institutes of Health and American Heart Association.
- 8 September 2025
- Published by Wiley in Obesity Reviews
- Vol. 27 (2) , e70017
Examining the Role of Sleep in Body Weight Regulation and Implications for Obesity Treatment: A Narrative Review
Despite significant public health efforts to counter the obesity epidemic, approximately 50% of US adults will have obesity by 2030. The cornerstone of obesity treatment is a behavioral intervention promoting negative energy balance via a reduced‐calorie diet and increased physical activity. Behavioral treatment also requires additional support to promote adherence to these recommended lifestyle changes. More recently, sleep has been recognized as an important component of body weight regulation due to its effects on physiological and behavioral determinants of energy balance. Therefore, sleep may represent a modifiable behavior to target during the behavioral treatment of obesity. This review summarizes existing clinical evidence on the influence of sleep on energy balance and body weight regulation in adults. The results of controlled laboratory studies as well as pragmatic clinical trials are reviewed. In addition, we identify existing gaps and future areas of research that are necessary to understand the role of sleep in behavioral treatments for obesity.
- 8 September 2025
- Published by Wiley in Obesity Reviews
- Vol. 27 (2) , e70017
Examining the Role of Sleep in Body Weight Regulation and Implications for Obesity Treatment: A Narrative Review
Despite significant public health efforts to counter the obesity epidemic, approximately 50% of US adults will have obesity by 2030. The cornerstone of obesity treatment is a behavioral intervention promoting negative energy balance via a reduced‐calorie diet and increased physical activity. Behavioral treatment also requires additional support to promote adherence to these recommended lifestyle changes. More recently, sleep has been recognized as an important component of body weight regulation due to its effects on physiological and behavioral determinants of energy balance. Therefore, sleep may represent a modifiable behavior to target during the behavioral treatment of obesity. This review summarizes existing clinical evidence on the influence of sleep on energy balance and body weight regulation in adults. The results of controlled laboratory studies as well as pragmatic clinical trials are reviewed. In addition, we identify existing gaps and future areas of research that are necessary to understand the role of sleep in behavioral treatments for obesity.
- Open Access
Effects of 4:3 Intermittent Fasting on Eating Behaviors and Appetite Hormones: A Secondary Analysis of a 12-Month Behavioral Weight Loss Intervention
Background/Objectives: Daily caloric restriction (DCR) is a common dietary weight loss strategy, but leads to metabolic and behavioral adaptations, including maladaptive eating behaviors and dysregulated appetite. Intermittent fasting (IMF) may mitigate these effects by offering diet flexibility during energy restriction. This secondary analysis compared changes in eating behaviors and appetite-related hormones between 4:3 intermittent fasting (4:3 IMF) and DCR and examined their association with weight loss over 12 months. Methods: Adults with overweight or obesity were randomized to 4:3 IMF or DCR for 12 months. Both randomized groups received a matched targeted weekly dietary energy deficit (34%), comprehensive group-based behavioral support, and a prescription to increase moderate-intensity aerobic activity to 300 min/week. Eating behaviors were assessed using validated questionnaires at baseline and months 3, 6, and 12. Fasting levels of leptin, ghrelin, peptide YY, brain-derived neurotrophic factor, and adiponectin were measured at baseline and months 6 and 12. Linear mixed models and Pearson correlations were used to evaluate outcomes. Results: Included in this analysis were 165 adults (mean ± SD; age 42 ± 9 years, BMI 34.2 ± 4.3 kg/m2, 74% female) randomized to 4:3 IMF (n = 84) or DCR (n = 81). At 12 months, binge eating and uncontrolled eating scores decreased in 4:3 IMF but increased in DCR (p < 0.01 for between-group differences). Among 4:3 IMF, greater weight loss was associated with decreased uncontrolled eating (r = −0.27, p = 0.03), emotional eating (r = −0.37, p < 0.01), and increased cognitive restraint (r = 0.35, p < 0.01) at 12 months. There were no between-group differences in changes in fasting appetite-related hormones at any time point. Conclusions: Compared to DCR, 4:3 IMF exhibited improved binge eating and uncontrolled eating behaviors at 12 months. This may, in part, explain the greater weight loss achieved by 4:3 IMF versus DCR. Future studies should examine mechanisms underlying eating behavior changes with 4:3 IMF and their long-term sustainability.
Open AccessEffects of 4:3 Intermittent Fasting on Eating Behaviors and Appetite Hormones: A Secondary Analysis of a 12-Month Behavioral Weight Loss Intervention
Background/Objectives: Daily caloric restriction (DCR) is a common dietary weight loss strategy, but leads to metabolic and behavioral adaptations, including maladaptive eating behaviors and dysregulated appetite. Intermittent fasting (IMF) may mitigate these effects by offering diet flexibility during energy restriction. This secondary analysis compared changes in eating behaviors and appetite-related hormones between 4:3 intermittent fasting (4:3 IMF) and DCR and examined their association with weight loss over 12 months. Methods: Adults with overweight or obesity were randomized to 4:3 IMF or DCR for 12 months. Both randomized groups received a matched targeted weekly dietary energy deficit (34%), comprehensive group-based behavioral support, and a prescription to increase moderate-intensity aerobic activity to 300 min/week. Eating behaviors were assessed using validated questionnaires at baseline and months 3, 6, and 12. Fasting levels of leptin, ghrelin, peptide YY, brain-derived neurotrophic factor, and adiponectin were measured at baseline and months 6 and 12. Linear mixed models and Pearson correlations were used to evaluate outcomes. Results: Included in this analysis were 165 adults (mean ± SD; age 42 ± 9 years, BMI 34.2 ± 4.3 kg/m2, 74% female) randomized to 4:3 IMF (n = 84) or DCR (n = 81). At 12 months, binge eating and uncontrolled eating scores decreased in 4:3 IMF but increased in DCR (p < 0.01 for between-group differences). Among 4:3 IMF, greater weight loss was associated with decreased uncontrolled eating (r = −0.27, p = 0.03), emotional eating (r = −0.37, p < 0.01), and increased cognitive restraint (r = 0.35, p < 0.01) at 12 months. There were no between-group differences in changes in fasting appetite-related hormones at any time point. Conclusions: Compared to DCR, 4:3 IMF exhibited improved binge eating and uncontrolled eating behaviors at 12 months. This may, in part, explain the greater weight loss achieved by 4:3 IMF versus DCR. Future studies should examine mechanisms underlying eating behavior changes with 4:3 IMF and their long-term sustainability.
- Open Access
Exploring Strategies to Promote Exercise as a Viable Obesity and Chronic Disease Treatment
Obesity and its related comorbidities continue to be a primary public health concern, especially in the United States (US). Such comorbidities include the top two causes of death in the US: cardiovascular disease and cancer. Obesity is also associated with several other chronic conditions that affect millions of adults and children, including diabetes, kidney, and liver disease. Weight loss has long been considered the front-line treatment and prevention strategy for these conditions. Lifestyle approaches, including dietary modification and increasing physical activity, are typically recommended for individuals with obesity, although rates of achieving and maintaining clinically meaningful weight loss remain low. Understanding the root causes of minimal weight loss and weight regain has been a prime focus among many researchers over the past several decades. The present review addresses several advantages of prioritizing exercise as an obesity and chronic disease treatment. We discuss current challenges when exercise is the primary treatment strategy, including physiological parameters that may influence the efficacy of exercise in addition to behavioral and environmental factors that play a role in exercise adherence and adoption. We also explore strategies and principles that, although not commonly utilized in an obesity/chronic disease treatment setting, may be applied and adapted to fit this model.
Open AccessExploring Strategies to Promote Exercise as a Viable Obesity and Chronic Disease Treatment
Obesity and its related comorbidities continue to be a primary public health concern, especially in the United States (US). Such comorbidities include the top two causes of death in the US: cardiovascular disease and cancer. Obesity is also associated with several other chronic conditions that affect millions of adults and children, including diabetes, kidney, and liver disease. Weight loss has long been considered the front-line treatment and prevention strategy for these conditions. Lifestyle approaches, including dietary modification and increasing physical activity, are typically recommended for individuals with obesity, although rates of achieving and maintaining clinically meaningful weight loss remain low. Understanding the root causes of minimal weight loss and weight regain has been a prime focus among many researchers over the past several decades. The present review addresses several advantages of prioritizing exercise as an obesity and chronic disease treatment. We discuss current challenges when exercise is the primary treatment strategy, including physiological parameters that may influence the efficacy of exercise in addition to behavioral and environmental factors that play a role in exercise adherence and adoption. We also explore strategies and principles that, although not commonly utilized in an obesity/chronic disease treatment setting, may be applied and adapted to fit this model.
- Open Access
- 21 May 2025
- Published by Springer Nature in International Journal of Behavioral Nutrition and Physical Activity
- Vol. 22 (1) , 1-9
Effect of physical activity on changes in weight and aerobic capacity during an 18-month behavioral weight loss intervention
Background: The objective of this secondary analysis was to examine the effect of MVPA and the time of day that MVPA (i.e., morning vs. evening) is performed on long-term changes in body weight and aerobic capacity. Methods: Adults with overweight and obesity (n = 105) enrolled in an 18-month behavioral weight loss intervention involving a reduced calorie diet and a supervised exercise program. Participants were encouraged to increase their bouted MVPA (i.e., MVPA accumulated in bouts ≥ 10 min) to 300 min/wk. Body weight, body composition, aerobic capacity, and physical activity were assessed at 0, 6, 12, and 18 months. Participants were categorized based on whether they increased bouted MVPA by ≥ 150 min/wk during the supervised exercise program. Linear regression was used to examine the effect of increasing bouted MVPA on weight loss and aerobic capacity. Similar methods were used to examine the effect of time of day of MVPA on weight loss and aerobic capacity. Results: Participants who increased bouted MVPA by ≥ 150 min/wk during the supervised exercise program had greater weight loss, fat loss, and increases in aerobic capacity at 18 months compared to participants who increased bouted MVPA by < 150 min/wk. Amongst participants who increased bouted MVPA by ≥ 150 min/wk, the time of day of MVPA had no significant effect on weight loss or aerobic capacity. Conclusions: Increasing bouted MVPA by ≥ 150 min/wk improves weight loss and aerobic capacity during a behavioral weight loss intervention which includes caloric restriction. MVPA earlier and later in the day is beneficial for weight management and cardiorespiratory fitness. Trial registration: Clinicaltrials.gov (NCT01985568) on October 24, 2013.
- 21 May 2025
- Published by Springer Nature in International Journal of Behavioral Nutrition and Physical Activity
- Vol. 22 (1) , 1-9
Open AccessEffect of physical activity on changes in weight and aerobic capacity during an 18-month behavioral weight loss intervention
Background: The objective of this secondary analysis was to examine the effect of MVPA and the time of day that MVPA (i.e., morning vs. evening) is performed on long-term changes in body weight and aerobic capacity. Methods: Adults with overweight and obesity (n = 105) enrolled in an 18-month behavioral weight loss intervention involving a reduced calorie diet and a supervised exercise program. Participants were encouraged to increase their bouted MVPA (i.e., MVPA accumulated in bouts ≥ 10 min) to 300 min/wk. Body weight, body composition, aerobic capacity, and physical activity were assessed at 0, 6, 12, and 18 months. Participants were categorized based on whether they increased bouted MVPA by ≥ 150 min/wk during the supervised exercise program. Linear regression was used to examine the effect of increasing bouted MVPA on weight loss and aerobic capacity. Similar methods were used to examine the effect of time of day of MVPA on weight loss and aerobic capacity. Results: Participants who increased bouted MVPA by ≥ 150 min/wk during the supervised exercise program had greater weight loss, fat loss, and increases in aerobic capacity at 18 months compared to participants who increased bouted MVPA by < 150 min/wk. Amongst participants who increased bouted MVPA by ≥ 150 min/wk, the time of day of MVPA had no significant effect on weight loss or aerobic capacity. Conclusions: Increasing bouted MVPA by ≥ 150 min/wk improves weight loss and aerobic capacity during a behavioral weight loss intervention which includes caloric restriction. MVPA earlier and later in the day is beneficial for weight management and cardiorespiratory fitness. Trial registration: Clinicaltrials.gov (NCT01985568) on October 24, 2013.
- Top Cited PapersOpen Access
- 6 May 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (9) , e039373
Advancing Chrononutrition for Cardiometabolic Health: A 2023 National Heart, Lung, and Blood Institute Workshop Report
The circadian system maintains optimal biological functions at the appropriate time of day, and the disruption of this organization can contribute to the pathogenesis of cardiometabolic disorders. The timing of eating is a prominent external time cue that influences the circadian system. “Chrononutrition” is an emerging dimension of nutrition and active area of research that examines how timing‐related aspects of eating and nutrition impact circadian rhythms, biological processes, and disease pathogenesis. There is evidence to support chrononutrition as a form of chronotherapy, such that optimizing the timing of eating may serve as an actionable strategy to improve cardiometabolic health. This report summarizes key information from the National Heart, Lung, and Blood Institute's virtual workshop entitled “Chrononutrition: Elucidating the Role of Circadian Biology and Meal Timing in Cardiometabolic Health,” which convened on May 2 to 3, 2023, to review current literature and identify critical knowledge gaps and research opportunities. The speakers presented evidence highlighting the impact on cardiometabolic health of earlier and shorter eating windows and more consistent day‐to‐day eating patterns. The multidimensionality of chrononutrition was a common theme, as it encompasses multiple facets of eating along with the timing of other behaviors including sleep and physical activity. Advancing the emerging field of chrononutrition will require: (1) standardization of terminology and metrics; (2) scalable and precise tools for real‐world settings; (3) consideration of individual differences that may act as effect modifiers; and (4) deeper understanding of social, behavioral, and cultural influences. Ultimately, there is great potential for circadian‐based dietary interventions to improve cardiometabolic health.
- 6 May 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (9) , e039373
Top Cited PapersOpen AccessAdvancing Chrononutrition for Cardiometabolic Health: A 2023 National Heart, Lung, and Blood Institute Workshop Report
The circadian system maintains optimal biological functions at the appropriate time of day, and the disruption of this organization can contribute to the pathogenesis of cardiometabolic disorders. The timing of eating is a prominent external time cue that influences the circadian system. “Chrononutrition” is an emerging dimension of nutrition and active area of research that examines how timing‐related aspects of eating and nutrition impact circadian rhythms, biological processes, and disease pathogenesis. There is evidence to support chrononutrition as a form of chronotherapy, such that optimizing the timing of eating may serve as an actionable strategy to improve cardiometabolic health. This report summarizes key information from the National Heart, Lung, and Blood Institute's virtual workshop entitled “Chrononutrition: Elucidating the Role of Circadian Biology and Meal Timing in Cardiometabolic Health,” which convened on May 2 to 3, 2023, to review current literature and identify critical knowledge gaps and research opportunities. The speakers presented evidence highlighting the impact on cardiometabolic health of earlier and shorter eating windows and more consistent day‐to‐day eating patterns. The multidimensionality of chrononutrition was a common theme, as it encompasses multiple facets of eating along with the timing of other behaviors including sleep and physical activity. Advancing the emerging field of chrononutrition will require: (1) standardization of terminology and metrics; (2) scalable and precise tools for real‐world settings; (3) consideration of individual differences that may act as effect modifiers; and (4) deeper understanding of social, behavioral, and cultural influences. Ultimately, there is great potential for circadian‐based dietary interventions to improve cardiometabolic health.
- 1 May 2025
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 178 (5) , 634-644
The Effect of 4:3 Intermittent Fasting on Weight Loss at 12 Months
Long-term (≥12 months) randomized trials evaluating the efficacy of intermittent fasting (IMF) as a dietary weight loss strategy are limited. Furthermore, no studies have compared IMF versus daily caloric restriction (DCR) when both interventions are provided in the context of a guidelines-based behavioral weight loss program. To compare the effects of 4:3 IMF versus DCR on changes in weight at 12 months, with comprehensive behavioral support provided to both groups. Randomized clinical trial. (ClinicalTrials.gov: NCT03411356). Denver, Colorado, and surrounding metropolitan area. Adults aged 18 to 60 years with body mass index (BMI) of 27 to 46 kg/m2. The IMF group was instructed to restrict energy intake by 80% on 3 nonconsecutive days per week, with ad libitum intake (no restriction) the other 4 days (4:3 IMF). The DCR group was instructed to reduce daily energy intake by 34% to match the weekly energy deficit of 4:3 IMF. Both groups received a high-intensity comprehensive behavioral weight loss program that included group-based behavioral support and a recommendation to increase moderate-intensity physical activity to 300 minutes per week. The primary outcome was change in body weight (in kilograms) at 12 months. Of the 165 (4:3 IMF, n = 84; DCR, n = 81) randomly assigned participants (mean age, 42 years [SD, 9]; mean BMI, 34.1 kg/m2 [SD, 4.4]; 73.9% female), 125 completed the trial. In an intention-to-treat analysis, 4:3 IMF showed greater reductions in weight than DCR at 12 months (mean difference, 2.89 kg [95% CI, 5.65 to 0.14 kg]; P = 0.040). Limited generalizability. Compared with DCR, 4:3 IMF resulted in modestly greater weight loss among adults with overweight or obesity enrolled in a 12-month, high-intensity, comprehensive behavioral weight loss program. National Institute of Diabetes and Digestive and Kidney Diseases.
- 1 May 2025
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 178 (5) , 634-644
The Effect of 4:3 Intermittent Fasting on Weight Loss at 12 Months
Long-term (≥12 months) randomized trials evaluating the efficacy of intermittent fasting (IMF) as a dietary weight loss strategy are limited. Furthermore, no studies have compared IMF versus daily caloric restriction (DCR) when both interventions are provided in the context of a guidelines-based behavioral weight loss program. To compare the effects of 4:3 IMF versus DCR on changes in weight at 12 months, with comprehensive behavioral support provided to both groups. Randomized clinical trial. (ClinicalTrials.gov: NCT03411356). Denver, Colorado, and surrounding metropolitan area. Adults aged 18 to 60 years with body mass index (BMI) of 27 to 46 kg/m2. The IMF group was instructed to restrict energy intake by 80% on 3 nonconsecutive days per week, with ad libitum intake (no restriction) the other 4 days (4:3 IMF). The DCR group was instructed to reduce daily energy intake by 34% to match the weekly energy deficit of 4:3 IMF. Both groups received a high-intensity comprehensive behavioral weight loss program that included group-based behavioral support and a recommendation to increase moderate-intensity physical activity to 300 minutes per week. The primary outcome was change in body weight (in kilograms) at 12 months. Of the 165 (4:3 IMF, n = 84; DCR, n = 81) randomly assigned participants (mean age, 42 years [SD, 9]; mean BMI, 34.1 kg/m2 [SD, 4.4]; 73.9% female), 125 completed the trial. In an intention-to-treat analysis, 4:3 IMF showed greater reductions in weight than DCR at 12 months (mean difference, 2.89 kg [95% CI, 5.65 to 0.14 kg]; P = 0.040). Limited generalizability. Compared with DCR, 4:3 IMF resulted in modestly greater weight loss among adults with overweight or obesity enrolled in a 12-month, high-intensity, comprehensive behavioral weight loss program. National Institute of Diabetes and Digestive and Kidney Diseases.
- 16 December 2024
- Published by Springer Nature in Sports Medicine
- Vol. 55 (1) , 49-65
Circadian Regulation of Fatty Acid Metabolism in Humans: Is There Evidence of an Optimal Time Window for Maximizing Fat Oxidation During Exercise?
Exercise training performed at the intensity that elicits maximal fat oxidation improves cardiovascular function and metabolic health while simultaneously
- 16 December 2024
- Published by Springer Nature in Sports Medicine
- Vol. 55 (1) , 49-65
Circadian Regulation of Fatty Acid Metabolism in Humans: Is There Evidence of an Optimal Time Window for Maximizing Fat Oxidation During Exercise?
Exercise training performed at the intensity that elicits maximal fat oxidation improves cardiovascular function and metabolic health while simultaneously